Marco Viceconti spent the last 15 years pursuing the vision that computer models could be used to assess the safety and efficacy of new medical products:
- Co-author of the 2005 white paper which introduced the term “Virtual Physiological Human”
- Coordinator of the 2007 first research roadmap on in silico medicine
- Lead author of the 2011 Position Statement on FP8, which introduced the concept of in silico trials
- Founder (2010), first Director (2011) and President (2015-2019) of the VPH Institute
- Founder and first director of the Insigneo Institute for In Silico Medicine (2011-2018), the largest research institute in Europe entirely dedicated to in silico medicine
- Coordinator of the support action 2013-2015 that established the Avicenna Alliance and member of its Board of Directors
He is currently full professor of Industrial Bioengineering in the Department of Industrial Engineering of the Alma Mater Studiorum – University of Bologna, Italy.
Communication Officer and Community Manager of the In Silico World website and community of practice, Roberta De Michele has a MD and PhD in Web Communication and Analysis of the Digital Business Scenarios.
She also manages the communication, dissemination and engagement activities for the EU-funded STriTuVaD and CompBioMed projects and the InSilicoMedicine research group at the University of Bologna.